Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Cervical cancer
Closed
Phase 3
This trial is looking at pembrolizumab for cervical cancer that has spread into the surrounding tissue (locally advanced) and has a high risk of coming back.
Recruitment start: 21 May 2021
Recruitment end: 18 November 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Susan Lalondrelle
Merck Sharp & Dohme Ltd
Last reviewed: 21 November 2022
CRUK internal database number: 17441